摘要 |
<p>A pharmaceutical composition for topical treatment of psoriasis and other hyperkeratotic and/or scaly dermatoses containing mometasone furoate (0,1 %) and salicylic acid (5 %) in a pharmaceutically acceptable vehicle and a method of using the pharmaceutical composition to treat psoriasis and hyperkeratotic scaly dermatoses are disclosed.</p> |